Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2012-05-24
Product name
DOCETAXEL EBEWE (EBEDOCE)
1.2.1 Relevant identified uses
Finished medicinal product
Icons in SDS
Company Information
company name
SANDOZ Oncology Injectables
e-mail address of the competent person responsible for the Safety Data Sheet
ask.oncology@sandoz.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H341, H360FD, H373
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
Hazard statements
Highly flammable, Toxic, Harmful Highly flammable liquid and vapour. Suspected of causing genetic defects. May damage fertility. May damage the unborn child. May cause damage to organs through prolonged or repeated exposure. H225 Highly flammable liquid and vapour. H341 Suspected of causing genetic defects. H360FD May damage fertility. May damage the unborn child. H373 May cause damage to organs through prolonged or repeated exposure.
R-phrase(s)
May impair fertility. May cause harm to the unborn child. Highly flammable. May cause harm to breastfed babies.
Hazard categories
Flammable liquid: Flam. Liq. 2 Germ cell mutagenicity: Muta. 2 Reproductive toxicity: Repr. 1A Specific target organ toxicity - repeated exposure: STOT RE 2
Hazard pictograms
GHS02-GHS08
Signal word
Danger
Hazardous Ingredients
Docetaxel
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P210 Keep away from heat/sparks/open flames/hot surfaces. - No smoking. P308+P313 IF exposed or concerned: Get medical advice/attention. P403+P235 Store in a well-ventilated place. Keep cool. P405 Store locked up.
Supplemental label elements
According to EC-rules and correspondent national legislation, this product, being a ready medicine, is not subject to mandatory identification.
2.3 Other hazards
Not known.
